Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock
Author(s) -
Anthony Gordon,
Alexina J. Mason,
Neeraja Thirunavukkarasu,
Gavin D. Perkins,
Maurizio Cecconi,
Magda Cepkova,
David Pogson,
Hollmann D. Aya,
Aisha Anjum,
Gregory J. Frazier,
Shalini Santhakumaran,
Deborah Ashby,
Stephen J. Brett
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.10485
Subject(s) - medicine , vasopressin , septic shock , norepinephrine , shock (circulatory) , placebo , acute kidney injury , randomization , renal replacement therapy , intensive care , resuscitation , randomized controlled trial , kidney , anesthesia , sepsis , intensive care medicine , alternative medicine , pathology , dopamine
Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom